BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 4007129)

  • 1. Alpha-particle track autoradiographic study of the distribution of a [211At]-astatinated drug in normal tissues of the mouse.
    Mitchell JS; Brown I; Carpenter RN
    Experientia; 1985 Jul; 41(7):925-8. PubMed ID: 4007129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. alpha-Particle track autoradiography for localization of a 211At-astatinated drug.
    Mitchell JS; Brown I; Carpenter RN
    Experientia; 1983 Mar; 39(3):337-9. PubMed ID: 6825808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biodistribution of 6-[211At]astato-2-methyl-1,4-naphthoquinol bis(diphosphate salt) and 211At- in mice with a transplanted rectal adenocarcinoma.
    Brown I; Carpenter RN; Mitchell JS
    Int J Appl Radiat Isot; 1984 Sep; 35(9):843-7. PubMed ID: 6480147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The development of A [211At]-astatinated endoradiotherapeutic drug: Part I. Localization by alpha-particle autoradiography in a murine tumor model.
    Brown I; Carpenter RN; Mitchell JS
    Int J Radiat Oncol Biol Phys; 1992; 23(3):563-72. PubMed ID: 1612957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The development of a [211At]-astatinated endoradiotherapeutic drug: Part II. Therapeutic results for transplanted adenocarcinoma of the rectum in mice and associated studies.
    Brown I; Mitchell JS
    Int J Radiat Oncol Biol Phys; 1994 Apr; 29(1):115-24. PubMed ID: 8175418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 6-211 At-astato-2-methyl-1,4-naphthoquinol bis (disodium phosphate): a novel alpha-emitting potential anti-tumour drug.
    Brown I
    Int J Appl Radiat Isot; 1982 Jan; 33(1):75-6. PubMed ID: 7061164
    [No Abstract]   [Full Text] [Related]  

  • 7. Radioactive derivatives of 2-methyl-1, 4-naphthoquinol bis (diphosphate salt) as anti-cancer drugs with high LET radiations.
    Mitchell JS; Brown I; Carpenter RN
    Prog Clin Biol Res; 1984; 166():327-35. PubMed ID: 6504938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The development of a [211AT]-astatinated endoradiotherapeutic drug: part IV--late radiation effects.
    Brown I; Mitchell JS
    Int J Radiat Oncol Biol Phys; 1998 Mar; 40(5):1177-83. PubMed ID: 9539575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and preliminary evaluation of 4-[211At]astato-N-piperidinoethyl benzamide.
    Garg PK; John CS; Zalutsky MR
    Nucl Med Biol; 1995 May; 22(4):467-73. PubMed ID: 7550023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3-[211At]astato-4-fluorobenzylguanidine: a potential therapeutic agent with prolonged retention by neuroblastoma cells.
    Vaidyanathan G; Zhao XG; Larsen RH; Zalutsky MR
    Br J Cancer; 1997; 76(2):226-33. PubMed ID: 9231923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 211At- and 131I-labeled bisphosphonates with high in vivo stability and bone accumulation.
    Larsen RH; Murud KM; Akabani G; Hoff P; Bruland OS; Zalutsky MR
    J Nucl Med; 1999 Jul; 40(7):1197-203. PubMed ID: 10405142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myelotoxicity and RBE of 211At-conjugated monoclonal antibodies compared with 99mTc-conjugated monoclonal antibodies and 60Co irradiation in nude mice.
    Elgqvist J; Bernhardt P; Hultborn R; Jensen H; Karlsson B; Lindegren S; Warnhammar E; Jacobsson L
    J Nucl Med; 2005 Mar; 46(3):464-71. PubMed ID: 15750160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reagents for astatination of biomolecules. 2. Conjugation of anionic boron cage pendant groups to a protein provides a method for direct labeling that is stable to in vivo deastatination.
    Wilbur DS; Chyan MK; Hamlin DK; Vessella RL; Wedge TJ; Hawthorne MF
    Bioconjug Chem; 2007; 18(4):1226-40. PubMed ID: 17583925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Animal studies on the in vivo stability of 211At-labelled albumin particles.
    Wunderlich G; Henke E; Iwe B; Franke WG; Fischer S; Dreyer R
    Nucl Med Commun; 1986 Apr; 7(4):211-4. PubMed ID: 3725235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blocking [211At]astatide accumulation in normal tissues: preliminary evaluation of seven potential compounds.
    Larsen RH; Slade S; Zalutsky MR
    Nucl Med Biol; 1998 May; 25(4):351-7. PubMed ID: 9639296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reagents for astatination of biomolecules: comparison of the in vivo distribution and stability of some radioiodinated/astatinated benzamidyl and nido-carboranyl compounds.
    Wilbur DS; Chyan MK; Hamlin DK; Kegley BB; Risler R; Pathare PM; Quinn J; Vessella RL; Foulon C; Zalutsky M; Wedge TJ; Hawthorne MF
    Bioconjug Chem; 2004; 15(1):203-23. PubMed ID: 14733601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac effects of menadione and its semiquinone.
    Carpenedo F; Floreani M; Santi Soncin E
    Cell Biol Int Rep; 1987 Jan; 11(1):63. PubMed ID: 3030570
    [No Abstract]   [Full Text] [Related]  

  • 18. Uptake and therapeutic effectiveness of 125I- and 211At-methylene blue for pigmented melanoma in an animal model system.
    Link EM; Brown I; Carpenter RN; Mitchell JS
    Cancer Res; 1989 Aug; 49(15):4332-7. PubMed ID: 2743321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Characteristics of distribution and elimination of DOPA-H3 and naphthidone-H3 in various forms of tumors].
    Shishkina VV; Chebotareva ED; Bobrova VN; Korolev VI; Idlis SM
    Vrach Delo; 1978 Jun; (6):96-100. PubMed ID: 695486
    [No Abstract]   [Full Text] [Related]  

  • 20. Targeting against epidermal growth factor receptors. Cellular processing of astatinated EGF after binding to cultured carcinoma cells.
    Orlova A; Sjöstrom A; Lebeda O; Lundqvist H; Carlsson J; Tolmachev V
    Anticancer Res; 2004; 24(6):4035-41. PubMed ID: 15736449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.